Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2010-11-16 Earnings Release
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Orexo announces new sales figures for Abstral™ from its partner ProStrakan and updates on the US approval
Earnings Release Classification · 1% confidence The document is a short announcement from Orexo AB dated November 16, 2010. It reports on sales figures for a product (Abstral) from its partner (ProStrakan) and provides an update on the US FDA approval process (REMS status). The content focuses on recent operational and sales performance updates, rather than a comprehensive annual or interim financial report, a formal earnings release (ER) which usually contains full period financials, or a management discussion (MDA). Since it provides key highlights and updates on business progress following another company's interim report, it best fits the description of an Earnings Release (ER) which often includes key performance indicators and operational milestones, even if it's not the formal quarterly filing itself. Given the context of reporting sales figures and progress updates, ER is the most appropriate classification among the choices, although it is brief. It is not a Report Publication Announcement (RPA) because it contains substantive news, not just a notice that a report is available. FY 2010
2010-11-16 English
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report, January-September 2010' for Orexo AB. It contains comprehensive financial statements, including a condensed consolidated statement of operations, revenue breakdowns, and management commentary on business performance for the specified interim period. It is not a mere announcement or certification, but the full interim financial report itself, fitting the definition of an Interim/Quarterly Report (IR). 9M 2010
2010-11-10 English
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 1% confidence The document is a 'delårsrapport' (interim report) for Orexo AB covering the period January-September 2010. It contains detailed financial statements, including income statements, cash flow analysis, and management commentary on business performance, product sales, and strategic developments. As it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. 9M 2010
2010-11-10 Swedish
Orexo stärker dotterbolaget Kibion genom att rekrytera Petter Bäckgren som VD
Board/Management Information Classification · 1% confidence The document is a press release dated October 27, 2010, announcing the appointment of Petter Bäckgren as the new CEO for Orexo's subsidiary, Kibion. This constitutes an announcement of a change in senior management. Based on the definitions, this aligns perfectly with the 'Board/Management Information' category (MANG). The document is short and is a direct announcement, not a comprehensive report or a general regulatory filing.
2010-10-27 Swedish
Orexo strengthens its subsidiary Kibion by recruiting Petter Bäckgren as CEO
Board/Management Information Classification · 1% confidence The document is a press release dated October 27, 2010, announcing a change in senior management: the appointment of a new CEO for a subsidiary (Kibion). This directly aligns with the definition for Board/Management Information (MANG), which covers announcements of changes in senior management. The document is not a full financial report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It is a specific personnel announcement.
2010-10-27 English
Valberedning inför Orexos årsstämma 2011 och finansiell kalender 2010/2011
AGM Information Classification · 1% confidence The document is a press release dated October 22, 2010, titled "Valberedning inför Orexos årsstämma 2011 och finansiell kalender 2010/2011" (Nomination Committee for Orexo's Annual General Meeting 2011 and Financial Calendar 2010/2011). The primary content discusses the composition of the Nomination Committee for the upcoming Annual General Meeting (AGM) 2011 and provides instructions for shareholders regarding proposals for the AGM. It also includes a financial calendar listing future report releases and the date of the AGM (April 7, 2011). Since the document announces the composition of the committee responsible for proposing candidates and matters for the AGM, and also details the AGM date, it is most closely related to the AGM process. However, it is not the AGM presentation itself (AGM-R) nor is it a proxy statement (PSI). It is an announcement related to the governance and scheduling of the AGM. Given the options, the content is highly specific to the preparation for the Annual General Meeting, which often involves the Nomination Committee. Since there isn't a specific code for 'Nomination Committee Announcement', and the document heavily focuses on the AGM structure and schedule, AGM-R (AGM Information) is the closest fit, although it is an announcement *about* the AGM rather than the meeting materials themselves. Alternatively, since it is a general regulatory announcement detailing governance structure changes related to the AGM, RNS (Regulatory Filings) could be considered. However, the specific mention of the Nomination Committee and the AGM date makes AGM-R a stronger thematic fit than the general fallback RNS, as it directly pertains to the AGM process.
2010-10-22 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.